You are here

A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Phoenix, Arizona, 85006 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
50 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Are men and women ≥ 50 years of age with a diagnosis of Alzheimers disease.

- Have a Mini-Mental State Exam between 5 and 14 inclusive.

- Have been taking the medication memantine (ie., Namenda) for at least six months prior
to this study.

- Must have a caregiver who assists the patient at least five days per week for at least
three hours per day, who can accompany patient to study visits, and who has an
intimate knowledge of the patient's health states and personal care.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Have taken medicines for Alzheimers disease other than memantine (e.g., donepezil,
rivastigmine, galantamine, tacrine) within 2 months prior to this study.

- Dementia other than Alzheimers disease.

- Any medical condition or reason that interferes with the ability of the patient to
participate in or complete the trial or places the patient at undue risk, as judged by
the study doctor.

NCT00912288
Pfizer
Terminated
A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Alzheimer Disease
NCT00996918
All Genders
51+
Years
Multiple Sites
Alzheimer Disease, Healthy Subjects
NCT00795730
All Genders
18+
Years
Glendale, California

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now